A citation-based method for searching scientific literature

Evgeny N Imyanitov, Aglaya G Iyevleva, Evgeny V Levchenko. Crit Rev Oncol Hematol 2021
Times Cited: 15







List of co-cited articles
32 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.
Ferdinandos Skoulidis, John V Heymach. Nat Rev Cancer 2019
154
6

The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-Analysis.
Cecilia Pop-Bica, Sebastian Pintea, Lorand Magdo, Roxana Cojocneanu, Diana Gulei, Manuela Ferracin, Ioana Berindan-Neagoe. Front Oncol 2020
2
50

The current state and future directions of RNAi-based therapeutics.
Ryan L Setten, John J Rossi, Si-Ping Han. Nat Rev Drug Discov 2019
326
6

Cellular uptake and trafficking of antisense oligonucleotides.
Stanley T Crooke, Shiyu Wang, Timothy A Vickers, Wen Shen, Xue-Hai Liang. Nat Biotechnol 2017
213
6

Pembrolizumab plus Chemotherapy in Lung Cancer.
Leena Gandhi, Marina C Garassino. N Engl J Med 2018
33
6

Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies.
Reham Ajina, David J Zahavi, Yong-Wei Zhang, Louis M Weiner. Semin Cancer Biol 2020
5
20


Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.
Tirsa L E van Westering, Yulia Lomonosova, Anna M L Coenen-Stass, Corinne A Betts, Amarjit Bhomra, Margriet Hulsker, Lucy E Clark, Graham McClorey, Annemieke Aartsma-Rus, Maaike van Putten,[...]. J Cachexia Sarcopenia Muscle 2020
13
7

miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer.
Sile Liu, Hongjing Zang, Hongmei Zheng, Weiyuan Wang, Qiuyuan Wen, Yuting Zhan, Yang Yang, Yue Ning, Haihua Wang, Songqing Fan. Sci Rep 2020
1
100


N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells.
Yang Wang, Yue Li, Julia I Toth, Matthew D Petroski, Zhaolei Zhang, Jing Crystal Zhao. Nat Cell Biol 2014
644
6

Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101.
Femke Stelma, Meike H van der Ree, Marjan J Sinnige, Anthony Brown, Leo Swadling, J Marleen L de Vree, Sophie B Willemse, Marc van der Valk, Paul Grint, Steven Neben,[...]. Hepatology 2017
20
6

Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways.
Ivan G Gomez, Deidre A MacKenna, Bryce G Johnson, Vivek Kaimal, Allie M Roach, Shuyu Ren, Naoki Nakagawa, Cuiyan Xin, Rick Newitt, Shweta Pandya,[...]. J Clin Invest 2015
204
6

Enzymatically synthesized 2'-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity.
Alesia A Levanova, Kiira M Kalke, Liisa M Lund, Nina Sipari, Mohammadreza Sadeghi, Marie C Nyman, Henrik Paavilainen, Veijo Hukkanen, Minna M Poranen. Antiviral Res 2020
4
25

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.
Marie Auvray, Edouard Auclin, Philippe Barthelemy, Petri Bono, Pirkko Kellokumpu-Lehtinen, Marine Gross-Goupil, Guillermo De Velasco, Thomas Powles, Guillaume Mouillet, Yann-Alexandre Vano,[...]. Eur J Cancer 2019
54
6

mRNA vaccines - a new era in vaccinology.
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
791
6

Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.
K M Taufiqul Arif, Esther K Elliott, Larisa M Haupt, Lyn R Griffiths. Cancers (Basel) 2020
18
6

The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1.
Ranjan Batra, David A Nelles, Daniela M Roth, Florian Krach, Curtis A Nutter, Takahiro Tadokoro, James D Thomas, Łukasz J Sznajder, Steven M Blue, Haydee L Gutierrez,[...]. Nat Biomed Eng 2021
11
9

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
Lisa A Jackson, Evan J Anderson, Nadine G Rouphael, Paul C Roberts, Mamodikoe Makhene, Rhea N Coler, Michele P McCullough, James D Chappell, Mark R Denison, Laura J Stevens,[...]. N Engl J Med 2020
6

Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.
Minhong Shen, Shanshan Xie, Michelle Rowicki, Sven Michel, Yong Wei, Xiang Hang, Liling Wan, Xin Lu, Min Yuan, John F Jin,[...]. Cancer Res 2021
7
14

Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.
Yuan Zhang, Nicole Mj Schwerbrock, Arlin B Rogers, William Y Kim, Leaf Huang. Mol Ther 2013
84
6

Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames.
Xue-Hai Liang, Wen Shen, Hong Sun, Michael T Migawa, Timothy A Vickers, Stanley T Crooke. Nat Biotechnol 2016
70
6

LncRNA SNHG16 drives proliferation, migration, and invasion of lung cancer cell through modulation of miR-520/VEGF axis.
L Chen, C-H Qiu, Y Chen, Y Wang, J-J Zhao, M Zhang. Eur Rev Med Pharmacol Sci 2020
4
25


Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
Katalin Karikó, Hiromi Muramatsu, Frank A Welsh, János Ludwig, Hiroki Kato, Shizuo Akira, Drew Weissman. Mol Ther 2008
451
6

The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors.
Aifu Lin, Qingsong Hu, Chunlai Li, Zhen Xing, Guolin Ma, Cheng Wang, Jun Li, Yin Ye, Jun Yao, Ke Liang,[...]. Nat Cell Biol 2017
134
6

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.
N J Caplen, S Parrish, F Imani, A Fire, R A Morgan. Proc Natl Acad Sci U S A 2001
798
6


Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer.
Bin Liu, Wen Cao, Guanglei Qiao, Shanying Yao, Shaojun Pan, Lirui Wang, Caixia Yue, Lijun Ma, Yanlei Liu, Daxiang Cui. Acta Biomater 2019
20
6

A step towards treating KRAS-mutant NSCLC.
Sarah B Goldberg, Joseph Schlessinger, Julie L Boyer, Roy S Herbst. Lancet Oncol 2013
6
16

Screening of the copy number increase of AKT in lung carcinoma by custom-designed MLPA.
Kentaro Minegishi, Yoh Dobashi, Hiroyoshi Tsubochi, Ryoko Tokuda, Koji Okudela, Akishi Ooi. Int J Clin Exp Pathol 2019
1
100

Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer.
Wanjun Gu, Junchao Shi, Hui Liu, Xudong Zhang, Jin J Zhou, Musheng Li, Dandan Zhou, Rui Li, Jingzhu Lv, Guoxia Wen,[...]. Mol Cancer 2020
7
14


N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.
Xiao Wang, Boxuan Simen Zhao, Ian A Roundtree, Zhike Lu, Dali Han, Honghui Ma, Xiaocheng Weng, Kai Chen, Hailing Shi, Chuan He. Cell 2015
6

Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study.
Ronald Natale, Fiona Blackhall, Dariusz Kowalski, Rodryg Ramlau, Gerold Bepler, Francesco Grossi, Christian Lerchenmüller, Mary Pinder-Schenck, Jörg Mezger, Sarah Danson,[...]. J Thorac Oncol 2014
19
6

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
Kartik Sehgal, Andreas Varkaris, Hollis Viray, Paul A VanderLaan, Deepa Rangachari, Daniel B Costa. J Immunother Cancer 2020
4
25

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.
Edmund C Lee, Tania Valencia, Charles Allerson, Annelie Schairer, Andrea Flaten, Matanel Yheskel, Kara Kersjes, Jian Li, Sole Gatto, Mandeep Takhar,[...]. Nat Commun 2019
35
6

RNA epigenetics--chemical messages for posttranscriptional gene regulation.
Ian A Roundtree, Chuan He. Curr Opin Chem Biol 2016
72
6

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Charles M Rudin, Ravi Salgia, Xiaofei Wang, Lydia D Hodgson, Gregory A Masters, Mark Green, Everett E Vokes. J Clin Oncol 2008
116
6

Functional and Structural Aspects of La Protein Overexpression in Lung Cancer.
Eleni G Kaliatsi, Aikaterini I Argyriou, Georgios Bouras, Maria Apostolidi, Parthena Konstantinidou, Athanasios-Nasir Shaukat, Georgios A Spyroulias, Constantinos Stathopoulos. J Mol Biol 2020
1
100

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Charles M Rudin, John T Poirier, Lauren Averett Byers, Caroline Dive, Afshin Dowlati, Julie George, John V Heymach, Jane E Johnson, Jonathan M Lehman, David MacPherson,[...]. Nat Rev Cancer 2019
204
6

OIP5-AS1 modulates epigenetic regulator HDAC7 to enhance non-small cell lung cancer metastasis via miR-140-5p.
Jiazhuan Mei, Guiju Liu, Wenhui Wang, Peng Xiao, Dan Yang, Hua Bai, Ruijun Li. Oncol Lett 2020
5
20

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Julian R Molina, Ping Yang, Stephen D Cassivi, Steven E Schild, Alex A Adjei. Mayo Clin Proc 2008
6

Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.
Nadza Tokaca, Andrew Wotherspoon, Andrew G Nicholson, Nicos Fotiadis, Lisa Thompson, Sanjay Popat. Lung Cancer 2017
9
11

AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.
Ewa Stepniak-Konieczna, Patryk Konieczny, Piotr Cywoniuk, Julia Dluzewska, Krzysztof Sobczak. Nucleic Acids Res 2020
5
20

Single-nucleotide polymorphism rs4142441 and MYC co-modulated long non-coding RNA OSER1-AS1 suppresses non-small cell lung cancer by sequestering ELAVL1.
Weijia Xie, Youhao Wang, Yao Zhang, Ying Xiang, Na Wu, Long Wu, Chengying Li, Tongjian Cai, Xiangyu Ma, Zubin Yu,[...]. Cancer Sci 2021
4
25

Discovering the first microRNA-targeted drug.
Morten Lindow, Sakari Kauppinen. J Cell Biol 2012
173
6

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression.
Kian Huat Lim, Zhou Han, Hyun Yong Jeon, Jacob Kach, Enxuan Jing, Sebastien Weyn-Vanhentenryck, Mikaela Downs, Anna Corrionero, Raymond Oh, Juergen Scharner,[...]. Nat Commun 2020
19
6

MicroRNA-99 family in cancer and immunity.
Joseph Eniafe, Shuai Jiang. Wiley Interdiscip Rev RNA 2021
4
25

5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo.
Reka A Haraszti, Loic Roux, Andrew H Coles, Anton A Turanov, Julia F Alterman, Dimas Echeverria, Bruno M D C Godinho, Neil Aronin, Anastasia Khvorova. Nucleic Acids Res 2017
39
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.